{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:59:14Z","timestamp":1773658754680,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T00:00:00Z","timestamp":1697932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Giant cell tumor of bone (GCTB) is a very rare tumor encountered in the jaws and its histology is quite similar to the more common giant cell granuloma of the jaws (GCGJ). These two entities can be easily confused in maxillofacial region. They are classically managed surgically, but in some localizations and in specific medical-surgical contexts, neoadjuvant therapy with denosumab may be indicated. This report tends to reinforce existing evidence in favor of the use of a neoadjuvant approach, particularly for localization of GCTB in the orofacial region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Presentation of case:<\/jats:title>\n                    <jats:p>This is a 57-year-old female patient, an alcoholic smoker, in whom a voluminous mandibular radiolucent lesion was discovered during a routine X-ray by her dentist. After medical imaging assessment and incisional biopsy, diagnosis of GCTB was established. A neoadjuvant denosumab therapy was proposed first followed by a secondary surgical curettage. After 4 years' follow-up, complete healing was observed with no recurrence of the lesion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Surgical management of aggressive GCTB is risky particularly in localizations involving the sacrum, spine or craniofacial skeleton with a high residual recurrence rate. The use of denosumab to stop tumor progression and facilitate secondary excision surgery is a recent approach that is now well documented in the literature showing promising results with a low rate of side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case of mandibular GCTB is to our knowledge the unique case described in this localization and treated by denosumab neoadjuvant therapy followed by surgery with a 4-year follow-up showing a complete healing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2023.108980","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T14:56:32Z","timestamp":1698677792000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Management of a rare mandibular giant cell tumor of bone by neoadjuvant denosumab therapy and surgery"],"prefix":"10.1097","volume":"112","author":[{"given":"Pierre","family":"Klienkoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00eblle","family":"Weingertner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine-Isabelle","family":"Gros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Emmanuel","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Bornert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-68-20260316","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0246-0521(12)57231-1","article-title":"Tumeurs \u00e0 cellules g\u00e9antes des os","volume":"7","author":"Gouin,","year":"2012","journal-title":"EMC - Appareil locomoteur"},{"key":"R4-68-20260316","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00428-014-1637-z","article-title":"A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50% of cells is stained","volume":"465","author":"Maues De Paula,","year":"2014","journal-title":"Virchows Arch"},{"key":"R5-68-20260316","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.annpat.2022.03.004","article-title":"La tumeur \u00e0 cellules g\u00e9antes des os en 2022","volume":"42","author":"Larousserie,","year":"2022","journal-title":"Ann. Pathol"},{"key":"R7-68-20260316","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/cancers13153647","article-title":"Current concepts in the treatment of giant cell tumors of bone","volume":"13","author":"Tsukamoto,","year":"2021","journal-title":"Cancers"},{"key":"R8-68-20260316","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/CCO.0000000000000852","article-title":"Updated concepts in treatment of giant cell tumor of bone","volume":"34","author":"van der Heijden,","year":"2022","journal-title":"Curr. Opin. Oncol"},{"key":"R9-68-20260316","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"Thomas,","year":"2010","journal-title":"Lancet Oncol"},{"key":"R10-68-20260316","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S1470-2045(19)30663-1","article-title":"Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study","volume":"20","author":"Chawla,","year":"2019","journal-title":"Lancet Oncol"},{"key":"R11-68-20260316","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00402-019-03167-x","article-title":"Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature","volume":"139","author":"Luengo-Alonso,","year":"2019","journal-title":"Arch. Orthop. Trauma Surg"},{"key":"R12-68-20260316","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11864-020-00766-4","article-title":"Role of (neo)adjuvant denosumab for giant cell tumor of bone","volume":"21","author":"Palmerini,","year":"2020","journal-title":"Curr. Treat. Options in Oncol"},{"key":"R13-68-20260316","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1302\/0301-620X.101B2.BJJ-2018-0907.R2","article-title":"Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone","volume":"101-B","author":"Puri,","year":"2019","journal-title":"Bone Jt. J"},{"key":"R14-68-20260316","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"84","author":"Agha,","year":"2020","journal-title":"Int. J. Surg"},{"key":"R15-68-20260316","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1542\/peds.103.6.1145","article-title":"Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a","volume":"103","author":"Kaban,","year":"1999","journal-title":"Pediatrics"},{"key":"R17-68-20260316","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1590\/S0104-42302009000200009","article-title":"Tumor de c\u00e9lulas gigantes de mand\u00edbula","volume":"55","author":"Senaga,","year":"2009","journal-title":"Rev. Assoc. Med. Bras"},{"key":"R18-68-20260316","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12663-011-0220-2","article-title":"Extensive giant cell tumour of the mandible: a case report with review","volume":"12","author":"Kulkarni,","year":"2013","journal-title":"J. Maxillofac. Oral Surg"},{"key":"R20-68-20260316","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3342\/ceo.2012.5.1.49","article-title":"Giant cell tumor of the mandible","volume":"5","author":"Park,","year":"2012","journal-title":"Clin. Exp. Otorhinolaryngol"},{"key":"R21-68-20260316","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12070-011-0407-3","article-title":"Giant cell tumour of mandible: report of a rare case","volume":"65","author":"Dehadaray,","year":"2013","journal-title":"Indian J. Otolaryngol. Head Neck Surg"},{"key":"R22-68-20260316","first-page":"88","article-title":"Giant cell tumor of infratemporal fossa and mandibular condyle: a case report","volume":"11","author":"June-Ho,","year":"2015","journal-title":"Int. Adv. Otol"},{"key":"R23-68-20260316","first-page":"81","article-title":"Giant cell tumor of mandibular condyle: a rarity","volume":"45","author":"Jaishankar,","year":"2017","journal-title":"J. Calif. Dent. Assoc"},{"key":"R24-68-20260316","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0973-029X.157217","article-title":"Giant cell tumor of the mandible","volume":"19","author":"Giri,","year":"2015","journal-title":"Oral Maxillofac. Pathol"},{"key":"R25-68-20260316","doi-asserted-by":"crossref","first-page":"e14087","DOI":"10.1016\/j.heliyon.2023.e14087","article-title":"Oral giant cell tumor or giant cell granuloma: how to know?","volume":"9","author":"Hoarau,","year":"2023","journal-title":"Heliyon"},{"key":"R26-68-20260316","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41379-021-00789-8","article-title":"Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors","volume":"34","author":"Agaimy,","year":"2021","journal-title":"Mod. Pathol"},{"key":"R27-68-20260316","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/PAS.0000000000002051","article-title":"Giant cell tumors with HMGA2::NCOR2 fusion: clinicopathologic, molecular, and epigenetic study of a distinct entity","volume":"47","author":"Perret,","year":"2023","journal-title":"Am. J. Surg. Pathol"},{"key":"R28-68-20260316","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1038\/s41467-018-06690-4","article-title":"TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw","volume":"9","author":"Gomes,","year":"2018","journal-title":"Nat. Commun"},{"key":"R29-68-20260316","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.humpath.2017.02.008","article-title":"Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls","volume":"63","author":"Roitman,","year":"2017","journal-title":"Hum. Pathol"},{"key":"R30-68-20260316","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.tripleo.2007.04.003","article-title":"Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options","volume":"104","author":"De Lange,","year":"2007","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod"},{"key":"R31-68-20260316","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/joms.2003.50129","article-title":"Calcitonin therapy for central giant cell granuloma","volume":"61","author":"Pogrel,","year":"2003","journal-title":"J. Oral Maxillofac. Surg"},{"key":"R32-68-20260316","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijscr.2015.02.001","article-title":"Injection of steroids intralesional in central giant cell granuloma cases (giant cell tumor): is it free of systemic complications or not? A case report","volume":"8","author":"El Hadidi,","year":"2015","journal-title":"Int. J. Surg. Case Rep"},{"key":"R34-68-20260316","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12891-020-03294-2","article-title":"Pre-operative denosumab is associated with higher risk of local recurrence in giant cell tumor of bone: a systematic review and meta-analysis","volume":"21","author":"Chen,","year":"2020","journal-title":"BMC Musculoskelet. Disord"},{"key":"R35-68-20260316","first-page":"230949902092978","article-title":"Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone","volume":"28","author":"Sano,","year":"2020","journal-title":"J. Orthop. Surg. (Hong Kong"},{"key":"R36-68-20260316","doi-asserted-by":"crossref","first-page":"508","DOI":"10.7150\/jca.50575","article-title":"Preoperative denosumab may increase the risk of local recurrence of giant-cell tumor of bone treated with curettage: a systematic review and Meta-analysis","volume":"12","author":"Zhao,","year":"2021","journal-title":"J. Cancer"},{"key":"R37-68-20260316","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","article-title":"Giant-cell tumor of bone","volume":"69","author":"Campanacci,","year":"1987","journal-title":"JBJS"},{"key":"R38-68-20260316","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s11999.0000000000000104","article-title":"Preoperative denosumab with curettage and cryotherapy in Giant cell tumor of bone: is there an increased risk of local recurrence?","volume":"476","author":"Scoccianti,","year":"2018","journal-title":"Clin. Orthop. Relat. Res"},{"key":"R39-68-20260316","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2017.01.028","article-title":"Denosumab in advanced\/unresectable giant-cell tumour of bone (GCTB): for how long?","volume":"76","author":"Palmerini,","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"R40-68-20260316","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/oncolo\/oyac066","article-title":"Giant cell tumor of bone: effect of longer dosing intervals of denosumab on tumor control and bone-related complications","volume":"27","author":"Jiang,","year":"2022","journal-title":"Oncologist"},{"key":"R42-68-20260316","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo,","year":"2010","journal-title":"J. Oral Maxillofac. Surg"},{"key":"R43-68-20260316","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws\u20142022 update","volume":"80","author":"Ruggiero,","year":"2022","journal-title":"J. Oral Maxillofac. Surg"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261223011094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261223011094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2023.108980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:01:23Z","timestamp":1773655283000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2023.108980"}},"subtitle":["A 4-year follow-up case report"],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":36,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2023.108980","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}